发明名称 |
METHOD FOR THERAPY FOR B-CELL MALIGNANCY USING ANTAGONIST ANTI-CD40 ANTIBODY |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide a method for therapy for B-cell malignancy. <P>SOLUTION: The method for therapy for B-cell malignancy is provided. The method comprises a process for administration of a therapeutically effective amount of an antagonist anti-CD40 antibody or antigen-binding fragment thereof to a patient in need thereof. The antagonist anti-CD40 antibody or antigen-binding fragment thereof is free of significant agonist activity when the antibody binds a CD40 antigen on a normal human B cell, exhibits antagonist activity when the antibody binds a CD40 antigen on a malignant human B cell, and can exhibit antagonist activity when the antibody binds a CD40 antigen on a normal human B cells. Antagonist activity of the anti-C antibody or antigen-binding fragment thereof beneficially inhibits proliferation and/or differentiation of malignant human B cells. <P>COPYRIGHT: (C)2008,JPO&INPIT |
申请公布号 |
JP2008074870(A) |
申请公布日期 |
2008.04.03 |
申请号 |
JP20070305086 |
申请日期 |
2007.11.26 |
申请人 |
CHIRON CORP |
发明人 |
CHU KETING;MASUOKA LORIANNE |
分类号 |
A61K39/395;C12N15/09;A61P1/04;A61P17/06;A61P19/02;A61P25/00;A61P29/00;A61P35/00;A61P37/00;A61P37/02;A61P37/06;A61P43/00;C07K16/18;C07K16/28;C07K16/30;C12N15/13;C12P21/08 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|